GLP-1 receptor agonists and cardiovascular disease: drug-specific or class effects?

被引：22
|
作者：
Zweck, Elric [1 ,2 ,3 ]
Roden, Michael [1 ,2 ,4 ]
机构：
[1] Heinrich Heine Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany
[2] German Ctr Diabet Res, Munich, Germany
[3] Heinrich Heine Univ, Fac Med, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany
[4] Heinrich Heine Univ, Fac Med, Div Endocrinol & Diabetol, Dusseldorf, Germany
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1016/S2213-8587(18)30351-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：89 / 90
页数：3
相关论文
共 50 条
  • [21] GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
    Zhao, Xin
    Wang, Minghe
    Wen, Zhitong
    Lu, Zhihong
    Cui, Lijuan
    Fu, Chao
    Xue, Huan
    Liu, Yunfeng
    Zhang, Yi
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [22] Otolaryngologic Side Effects of GLP-1 Receptor Agonists
    Khan, Faizaan I.
    Vazquez, Sebastian Guadarrama-Sistos
    Mehdi, Zain
    Somawardana, Isuru
    Dongre, Roshan
    Razmi, Samuel
    Rashidi, Keyvon
    Shenoi, Jason
    Khan, Najm
    Dhanda, Aatin
    Takashima, Masayoshi
    Ahmed, Omar G.
    LARYNGOSCOPE, 2025,
  • [23] Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
    Verge, Danilo
    Lopez, Ximena
    CURRENT DIABETES REVIEWS, 2010, 6 (04) : 191 - 200
  • [24] GLP-1 Receptor Agonists Improve Cardiovascular Outcomes in Patients With Celiac Disease and Obesity
    Nieto, Luis
    Narvaez, Sharon
    Shepherd, Katherine
    Adeniran, Olanrewaju
    Vega, Kenneth
    Haggerty, Treah
    Davisson, Laura
    OBESITY, 2024, 32 : 87 - 88
  • [25] GLP-1 Receptor Agonists and Cardiovascular Disease: What Do Clinicians Need to Know?
    Hayat, Javeria
    Shah, Nishant P.
    Agarwala, Anandita
    Khan, Muhammad Shahzeb
    Butler, Javed
    CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (08) : 341 - 351
  • [26] Cardiovascular Effects of Different GLP-1 Receptor Agonists in Patients with Type 2 Diabetes
    Bahtiyar, Gul
    Pujals-Kury, Jean
    Sacerdote, Alan
    CURRENT DIABETES REPORTS, 2018, 18 (10)
  • [27] DPP-4 inhibitors and GLP-1 receptor agonists. Cardiovascular effects
    Nauck, M. A.
    El Aziz, M. S. Abd
    Meier, J. J.
    DIABETOLOGE, 2016, 12 (03): : 184 - +
  • [28] Cardiovascular Effects of Different GLP-1 Receptor Agonists in Patients with Type 2 Diabetes
    Gül Bahtiyar
    Jean Pujals-Kury
    Alan Sacerdote
    Current Diabetes Reports, 2018, 18
  • [29] GLP-1 receptor agonists in NAFLD
    Petit, J. -M.
    Verges, B.
    DIABETES & METABOLISM, 2017, 43 : 2S28 - 2S33
  • [30] GLP-1 receptor agonists and suicidality
    Ueda, Peter
    Pasternak, Bjorn
    BMJ-BRITISH MEDICAL JOURNAL, 2025, 388
12345